Investing in the latest bone marrow / hematopoietic stem cell transplantation technology

Latest Announcements

18 Nov, 2022
HEMO-CAR-T Process Development Runs Completed
>
29 Sep, 2022
Half-year Report – Interim Results for the Period Ended 30 June 2022
>
01 Sep, 2022
Presentation at H.C. Wainwright Global Investment Conference
>
22 Aug, 2022
Appointment of Director of Quality
>
View all